Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria

Summary

The study is designed to assess the efficacy and safety of monthly injections of Omalizumab 150 mg for 3 consecutive months, in patients with chronic idiopathic urticaria, unresponsive to convetional therapy by antihistamins or oral corticosteroids.

Timeline

Start

2014-07

Primary completion

2016-06

Completion

2016-06

Drugs

Indications